JIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements

Bulletin Express03-04

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its overall registered share capital, which remained at 245.40 million RMB. Registered capital was composed of H shares, domestic shares, and unlisted foreign shares at 109.10 million shares, 105.30 million shares, and 31.00 million shares respectively, all with a par value of 1 RMB per share.

During February 2026, the H shares issued (excluding treasury shares) decreased from 108.32 million shares to 105.21 million shares, while treasury shares rose from 0.77 million shares to 3.88 million shares. A total of 3.11 million H shares were repurchased between 2 February 2026 and 12 February 2026 at prices ranging from HKD 9.82 to HKD 10.67 per share and were transferred into treasury. The company confirmed that it continues to meet the minimum public float requirement of 25% for its H shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126651865?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 17:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126651865","market":"hk","top_or_hot":-1,"title":"JIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements","media":"Bulletin Express","content":"<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its overall registered share capital, which remained at 245.40 million RMB. Registered capital was composed of H shares, domestic shares, and unlisted foreign shares at 109.10 million shares, 105.30 million shares, and 31.00 million shares respectively, all with a par value of 1 RMB per share.</p>\n<p>During February 2026, the H shares issued (excluding treasury shares) decreased from 108.32 million shares to 105.21 million shares, while treasury shares rose from 0.77 million shares to 3.88 million shares. A total of 3.11 million H shares were repurchased between 2 February 2026 and 12 February 2026 at prices ranging from HKD 9.82 to HKD 10.67 per share and were transferred into treasury. The company confirmed that it continues to meet the minimum public float requirement of 25% for its H shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJIUYUAN GENE (02566) Releases February 2026 Monthly Return on Equity Movements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-04 17:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its overall registered share capital, which remained at 245.40 million RMB. Registered capital was composed of H shares, domestic shares, and unlisted foreign shares at 109.10 million shares, 105.30 million shares, and 31.00 million shares respectively, all with a par value of 1 RMB per share.</p>\n<p>During February 2026, the H shares issued (excluding treasury shares) decreased from 108.32 million shares to 105.21 million shares, while treasury shares rose from 0.77 million shares to 3.88 million shares. A total of 3.11 million H shares were repurchased between 2 February 2026 and 12 February 2026 at prices ranging from HKD 9.82 to HKD 10.67 per share and were transferred into treasury. The company confirmed that it continues to meet the minimum public float requirement of 25% for its H shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02566","symbol_name":"九源基因","start_time":0,"source_url":"","article_id":"1126651865","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126651865","pubTimestamp":1772617764,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02566":"九源基因"},"translate_title":"玖源基因(02566)发布2026年2月股东权益变动月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02566":1},"content_text":"Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (JIUYUAN GENE, Stock Code: 02566) published its monthly return for equity movements as of 28 February 2026. The company reported no changes in its overall registered share capital, which remained at 245.40 million RMB. Registered capital was composed of H shares, domestic shares, and unlisted foreign shares at 109.10 million shares, 105.30 million shares, and 31.00 million shares respectively, all with a par value of 1 RMB per share.\nDuring February 2026, the H shares issued (excluding treasury shares) decreased from 108.32 million shares to 105.21 million shares, while treasury shares rose from 0.77 million shares to 3.88 million shares. A total of 3.11 million H shares were repurchased between 2 February 2026 and 12 February 2026 at prices ranging from HKD 9.82 to HKD 10.67 per share and were transferred into treasury. The company confirmed that it continues to meet the minimum public float requirement of 25% for its H shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126651865","isCrawlerRequest":true}